Cancer Drug Endpoints: ctDNA Promising But Presents Many Challenges, Experts Say

 
• By Sue Sutter
Long road
The road to establishing ctDNA as predictive of long-term outcomes in early-stage disease is a long one. • Source: Alamy

More from Clinical Trials

More from R&D